New antibody therapy for metastasised cancer
In a clinical study patients with spread cancer will be treated with antibodies that are injected directly into the metastases. Main responsible for the study is Gustav Ullenhag, researcher at IGP and senior consultant at Uppsala University Hospital.
When antibodies are used in tumour therapy today they are most often administered to the patient’s blood. In the new treatment the antibodies will instead be injected directly in the metastases. The aim is that this will activate the immune response so that also non-treated metastases are affected. It is also possible that this treatment will result in fewer side effects.
The new therapy is evaluated at Uppsala University Hospital and Karolinska University Hospital, and at clinical trial centres in Denmark and the UK.